In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
The American Gastroenterological Association believes gastroenterologists should play more of a role in obesity treatment, suggesting they are in a “unique position to lead the care team.”
